Cipla Sees 2% Gains on Zero Observations for Indore Facility
Share prices of Cipla gained 2.5 per cent in the early trade on Monday after USFDA issued zero observation for its Indore facility. At the...
Tag : USFDA
Sun Pharma Clarifies On Its Corporate Governance Issue
Sun Pharmaceutical Industries Ltd today made a press release, today, in order to clarify the ongoing corporate governance issue. Sun Pharma explained that the loan...
Wockhardt Ltd Receives USFDA Approval For Cancer Treatment Drug
Wockhardt Ltd. announced that the drugmaker has received approval from the U.S. health regulator, USFDA, for the generic version of Gleevec used for the treatment...
Pharmaceutical Majors Recall Their Products From USA
According to the latest U.S. Food and Drug Administration’s (USFDA) Enforcement Report, Indian pharma major such as Lupin, Sun Pharma and Glenmark has decided to...
US FDA Approves Zydus Cadila’s HIV-1 Treatment Tablets
Zydus Cadila has announced that the US health regulator has given final approval to market generic Abacavir and Lamivudine tablets, which are primarily used for...
Morepen Laboratories gets USFDA nod for Baddi facility
Morepen Laboratories has received approval for its Baddi facility at Himachal Pradesh, from USFDA. The company’s Baddi facility has received approval for the manufacture of bulk drug Atorvastatin...
Zydus Cadila gets USFDA approval for Piroxicam Capsules
Zydus Cadila has received final approval for Piroxicam Capsules USP in the strengths of 10 mg and 20 mg, from the US health regulator. This...
Cadila gets USFDA approval to market 4 generic products
Zydus Cadila has received final approvals from the US health regulator, to market four generic products in America. The approvals received are for Olanzapine tablets in strengths...
Glenmark Pharma receives USFDA nod for Colesevelam Hydrochloride
Glenmark Pharma has received final approval for Colesevelam Hydrochloride, from USFDA. Colesevelam Hydrochloride is a generic version of Welchol 1 of Daiichi Sankyo Inc and the...
Cadila Healthcare receives approval from USFDA for Zolmitriptan tablets
Cadila Healthcare has received final approval for Zolmitriptan tablets USP, from the USFDA. The company has received final approval to market Zolmitriptan Tablets, 2.5 mg and 5 mg,...